Researchers from Stanford, Princeton, Google DeepMind, and UC Berkeley have developed CRISPR-GPT, an AI-driven agentic system that automates the design and analysis of CRISPR gene-editing experiments. The large language model-based platform interacts with users across beginner to advanced levels, generating protocols, suggesting guide RNA designs, and answering technical questions. Trained on scientific literature and expert discussions, CRISPR-GPT democratizes gene-editing access and speeds experiment planning, representing a new frontier in AI-augmented biomedical research.